APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sugammadex

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Sugammadex Industry Growth and Trends Forecast to 2032

23 December 2025100 pages

Choose your research edition.

Industry ResearchSugammadex Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal Sugammadex Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Sugammadex Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sugammadex Market Outlook and Growth Opportunities 2026196 pages · $4,250 USDMarket Analysis & ForecastGlobal Sugammadex Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Sugammadex market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Sugammadex is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Sugammadex is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Sugammadex is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Sugammadex include Renfu Pharma, Yangzi River Pharma, Teva, Sandoz, Merck & Co, Kelun Pharma, Viatris, STADA Arzneimittel and Intas Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Sugammadex market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Sugammadex market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Sugammadex market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Sugammadex.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Sugammadex market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Sugammadex Market by Company

Renfu Pharma

Yangzi River Pharma

Teva

Sandoz

Merck & Co

Kelun Pharma

Viatris

STADA Arzneimittel

Intas Pharmaceuticals

Hikma Pharmaceuticals

Fresenius

Dr Reddy's Laboratories

Cipla

Aspen Group

Sugammadex Segment by Type

Vials

Ampoules

Sugammadex Segment by Application

Hospital

Mobile Surgery Centre

Sugammadex Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sugammadex market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sugammadex and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sugammadex.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Sugammadex manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Sugammadex in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Vials Table 2. Major Company of Ampoules Table 3. Global Sugammadex Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Sugammadex Sales by Type (2021-2026) & (k units) Table 5. Global Sugammadex Sales Market Share in Volume by Type (2021-2026) Table 6. Global Sugammadex Sales by Type (2021-2026) & (US$ Million) Table 7. Global Sugammadex Sales Market Share in Value by Type (2021-2026) Table 8. Global Sugammadex Price by Type (2021-2026) & (USD/unit) Table 9. Global Sugammadex Sales by Type (2027-2032) & (k units) Table 10. Global Sugammadex Sales Market Share in Volume by Type (2027-2032) Table 11. Global Sugammadex Sales by Type (2027-2032) & (US$ Million) Table 12. Global Sugammadex Sales Market Share in Value by Type (2027-2032) Table 13. Global Sugammadex Price by Type (2027-2032) & (USD/unit) Table 14. North America Sugammadex Sales by Type (2021-2026) & (k units) Table 15. North America Sugammadex Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Sugammadex Sales by Type (2021-2026) & (k units) Table 17. Europe Sugammadex Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Sugammadex Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Sugammadex Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Sugammadex Sales by Type (2021-2026) & (k units) Table 21. Latin America Sugammadex Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Sugammadex Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Sugammadex Sales by Type (2021-2026) & (US$ Million) Table 24. Sugammadex Industry Trends Table 25. Sugammadex Industry Drivers Table 26. Sugammadex Industry Opportunities and Challenges Table 27. Sugammadex Industry Restraints Table 28. Global Sugammadex Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Sugammadex Revenue Market Share by Company (2021-2026) Table 30. Global Sugammadex Sales by Company (2021-2026) & (k units) Table 31. Global Sugammadex Sales Share by Company (2021-2026) Table 32. Global Sugammadex Market Price by Company (2021-2026) & (USD/unit) Table 33. Global Sugammadex Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Sugammadex Major Company Production Sites and Headquarters Table 35. Global Sugammadex Company, Product Type & Application Table 36. Global Sugammadex Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Sugammadex by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Sugammadex Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Sugammadex Sales by Region (2021-2026) & (k units) Table 41. Global Sugammadex Sales Market Share in Volume by Region (2021-2026) Table 42. Global Sugammadex Sales by Region (2021-2026) & (US$ Million) Table 43. Global Sugammadex Sales Market Share in Value by Region (2021-2026) Table 44. Global Sugammadex Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 45. Global Sugammadex Sales by Region (2027-2032) & (k units) Table 46. Global Sugammadex Sales Market Share in Volume by Region (2027-2032) Table 47. Global Sugammadex Sales by Region (2027-2032) & (US$ Million) Table 48. Global Sugammadex Sales Market Share in Value by Region (2027-2032) Table 49. Global Sugammadex Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 50. Global Sugammadex Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Sugammadex Sales by Application (2021-2026) & (k units) Table 52. Global Sugammadex Sales Market Share in Volume by Application (2021-2026) Table 53. Global Sugammadex Sales by Application (2021-2026) & (US$ Million) Table 54. Global Sugammadex Sales Market Share in Value by Application (2021-2026) Table 55. Global Sugammadex Price by Application (2021-2026) & (USD/unit) Table 56. Global Sugammadex Sales by Application (2027-2032) & (k units) Table 57. Global Sugammadex Sales Market Share in Volume by Application (2027-2032) Table 58. Global Sugammadex Sales by Application (2027-2032) & (US$ Million) Table 59. Global Sugammadex Sales Market Share in Value by Application (2027-2032) Table 60. Global Sugammadex Price by Application (2027-2032) & (USD/unit) Table 61. North America Sugammadex Sales by Application (2021-2026) & (k units) Table 62. North America Sugammadex Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Sugammadex Sales by Application (2021-2026) & (k units) Table 64. Europe Sugammadex Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Sugammadex Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Sugammadex Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Sugammadex Sales by Application (2021-2026) & (k units) Table 68. Latin America Sugammadex Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Sugammadex Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Sugammadex Sales by Application (2021-2026) & (US$ Million) Table 71. Renfu Pharma Company Information Table 72. Renfu Pharma Business Overview Table 73. Renfu Pharma Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 74. Renfu Pharma Sugammadex Product Portfolio Table 75. Renfu Pharma Recent Development Table 76. Yangzi River Pharma Company Information Table 77. Yangzi River Pharma Business Overview Table 78. Yangzi River Pharma Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 79. Yangzi River Pharma Sugammadex Product Portfolio Table 80. Yangzi River Pharma Recent Development Table 81. Teva Company Information Table 82. Teva Business Overview Table 83. Teva Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 84. Teva Sugammadex Product Portfolio Table 85. Teva Recent Development Table 86. Sandoz Company Information Table 87. Sandoz Business Overview Table 88. Sandoz Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 89. Sandoz Sugammadex Product Portfolio Table 90. Sandoz Recent Development Table 91. Merck & Co Company Information Table 92. Merck & Co Business Overview Table 93. Merck & Co Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 94. Merck & Co Sugammadex Product Portfolio Table 95. Merck & Co Recent Development Table 96. Kelun Pharma Company Information Table 97. Kelun Pharma Business Overview Table 98. Kelun Pharma Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 99. Kelun Pharma Sugammadex Product Portfolio Table 100. Kelun Pharma Recent Development Table 101. Viatris Company Information Table 102. Viatris Business Overview Table 103. Viatris Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 104. Viatris Sugammadex Product Portfolio Table 105. Viatris Recent Development Table 106. STADA Arzneimittel Company Information Table 107. STADA Arzneimittel Business Overview Table 108. STADA Arzneimittel Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 109. STADA Arzneimittel Sugammadex Product Portfolio Table 110. STADA Arzneimittel Recent Development Table 111. Intas Pharmaceuticals Company Information Table 112. Intas Pharmaceuticals Business Overview Table 113. Intas Pharmaceuticals Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 114. Intas Pharmaceuticals Sugammadex Product Portfolio Table 115. Intas Pharmaceuticals Recent Development Table 116. Hikma Pharmaceuticals Company Information Table 117. Hikma Pharmaceuticals Business Overview Table 118. Hikma Pharmaceuticals Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 119. Hikma Pharmaceuticals Sugammadex Product Portfolio Table 120. Hikma Pharmaceuticals Recent Development Table 121. Fresenius Company Information Table 122. Fresenius Business Overview Table 123. Fresenius Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 124. Fresenius Sugammadex Product Portfolio Table 125. Fresenius Recent Development Table 126. Dr Reddy's Laboratories Company Information Table 127. Dr Reddy's Laboratories Business Overview Table 128. Dr Reddy's Laboratories Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 129. Dr Reddy's Laboratories Sugammadex Product Portfolio Table 130. Dr Reddy's Laboratories Recent Development Table 131. Cipla Company Information Table 132. Cipla Business Overview Table 133. Cipla Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 134. Cipla Sugammadex Product Portfolio Table 135. Cipla Recent Development Table 136. Aspen Group Company Information Table 137. Aspen Group Business Overview Table 138. Aspen Group Sugammadex Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 139. Aspen Group Sugammadex Product Portfolio Table 140. Aspen Group Recent Development Table 141. North America Sugammadex Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 142. North America Sugammadex Sales by Country (2021-2026) & (k units) Table 143. North America Sugammadex Sales Market Share by Country (2021-2026) Table 144. North America Sugammadex Sales Forecast by Country (2027-2032) & (k units) Table 145. North America Sugammadex Sales Market Share Forecast by Country (2027-2032) Table 146. North America Sugammadex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. North America Sugammadex Market Size by Country (2021-2026) & (US$ Million) Table 148. North America Sugammadex Market Share by Country (2021-2026) Table 149. North America Sugammadex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. North America Sugammadex Market Share Forecast by Country (2027-2032) Table 151. Europe Sugammadex Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 152. Europe Sugammadex Sales by Country (2021-2026) & (k units) Table 153. Europe Sugammadex Sales Market Share by Country (2021-2026) Table 154. Europe Sugammadex Sales Forecast by Country (2027-2032) & (k units) Table 155. Europe Sugammadex Sales Market Share Forecast by Country (2027-2032) Table 156. Europe Sugammadex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Europe Sugammadex Market Size by Country (2021-2026) & (US$ Million) Table 158. Europe Sugammadex Market Share by Country (2021-2026) Table 159. Europe Sugammadex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Europe Sugammadex Market Share Forecast by Country (2027-2032) Table 161. Asia-Pacific Sugammadex Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 162. Asia-Pacific Sugammadex Sales by Country (2021-2026) & (k units) Table 163. Asia-Pacific Sugammadex Sales Market Share by Country (2021-2026) Table 164. Asia-Pacific Sugammadex Sales Forecast by Country (2027-2032) & (k units) Table 165. Asia-Pacific Sugammadex Sales Market Share Forecast by Country (2027-2032) Table 166. Asia-Pacific Sugammadex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Asia-Pacific Sugammadex Market Size by Country (2021-2026) & (US$ Million) Table 168. Asia-Pacific Sugammadex Market Share by Country (2021-2026) Table 169. Asia-Pacific Sugammadex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Asia-Pacific Sugammadex Market Share Forecast by Country (2027-2032) Table 171. Latin America Sugammadex Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 172. Latin America Sugammadex Sales by Country (2021-2026) & (k units) Table 173. Latin America Sugammadex Sales Market Share by Country (2021-2026) Table 174. Latin America Sugammadex Sales Forecast by Country (2027-2032) & (k units) Table 175. Latin America Sugammadex Sales Market Share Forecast by Country (2027-2032) Table 176. Latin America Sugammadex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 177. Latin America Sugammadex Market Size by Country (2021-2026) & (US$ Million) Table 178. Latin America Sugammadex Market Share by Country (2021-2026) Table 179. Latin America Sugammadex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 180. Latin America Sugammadex Market Share Forecast by Country (2027-2032) Table 181. Middle East and Africa Sugammadex Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 182. Middle East and Africa Sugammadex Sales by Country (2021-2026) & (k units) Table 183. Middle East and Africa Sugammadex Sales Market Share by Country (2021-2026) Table 184. Middle East and Africa Sugammadex Sales Forecast by Country (2027-2032) & (k units) Table 185. Middle East and Africa Sugammadex Sales Market Share Forecast by Country (2027-2032) Table 186. Middle East and Africa Sugammadex Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 187. Middle East and Africa Sugammadex Market Size by Country (2021-2026) & (US$ Million) Table 188. Middle East and Africa Sugammadex Market Share by Country (2021-2026) Table 189. Middle East and Africa Sugammadex Market Size Forecast by Country (2027-2032) & (US$ Million) Table 190. Middle East and Africa Sugammadex Market Share Forecast by Country (2027-2032) Table 191. Key Raw Materials Table 192. Raw Materials Key Suppliers Table 193. Sugammadex Distributors List Table 194. Sugammadex Customers List Table 195. Research Programs/Design for This Report Table 196. Authors List of This Report Table 197. Secondary Sources Table 198. Primary Sources List of Figures Figure 1. Sugammadex Image Figure 2. Global Sugammadex Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sugammadex Market Size (2021-2032) & (US$ Million) Figure 4. Global Sugammadex Sales (2021-2032) & (k units) Figure 5. Vials Image Figure 6. Global Vials Sales YoY Growth (2021-2032) & (k units) Figure 7. Ampoules Image Figure 8. Global Ampoules Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Sugammadex Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Sugammadex Market Share by Type 2025 VS 2032 Figure 11. North America Sugammadex Sales Market Share in Volume by Type in 2025 Figure 12. North America Sugammadex Sales Market Share in Value by Type in 2025 Figure 13. Europe Sugammadex Sales Market Share in Volume by Type in 2025 Figure 14. Europe Sugammadex Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Sugammadex Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Sugammadex Sales Market Share in Value by Type in 2025 Figure 17. Latin America Sugammadex Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Sugammadex Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Sugammadex Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Sugammadex Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Sugammadex Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (k units) Figure 25. Mobile Surgery Centre Image Figure 26. Global Mobile Surgery Centre Sales YoY Growth (2021-2032) & (k units) Figure 27. Global Sugammadex Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Sugammadex Market Share by Application 2025 VS 2032 Figure 29. North America Sugammadex Sales Market Share in Volume by Application in 2025 Figure 30. North America Sugammadex Sales Market Share in Value by Application in 2025 Figure 31. Europe Sugammadex Sales Market Share in Volume by Application in 2025 Figure 32. Europe Sugammadex Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Sugammadex Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Sugammadex Sales Market Share in Value by Application in 2025 Figure 35. Latin America Sugammadex Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Sugammadex Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Sugammadex Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Sugammadex Sales Market Share in Value by Application in 2025 Figure 39. North America Sugammadex Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 40. North America Sugammadex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Sugammadex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Sugammadex Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Sugammadex Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. Europe Sugammadex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Sugammadex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Sugammadex Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Sugammadex Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Asia-Pacific Sugammadex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Sugammadex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Sugammadex Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Sugammadex Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Latin America Sugammadex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Sugammadex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Sugammadex Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Sugammadex Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Middle East and Africa Sugammadex Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Sugammadex Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Sugammadex Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Sugammadex Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Sugammadex Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Vials
  • Ampoules
Applications
  • Hospital
  • Mobile Surgery Centre
Companies covered
  • Renfu Pharma
  • Yangzi River Pharma
  • Teva
  • Sandoz
  • Merck & Co
  • Kelun Pharma
  • Viatris
  • STADA Arzneimittel
  • Intas Pharmaceuticals
  • Hikma Pharmaceuticals
  • Fresenius
  • Dr Reddy's Laboratories
  • Cipla
  • Aspen Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Sugammadex Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Sugammadex Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Sugammadex Market by Type
  6. 1.3.1 Vials
  7. 1.3.2 Ampoules
  8. 1.4 Global Sugammadex Market Size by Type
  9. 1.4.1 Global Sugammadex Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Sugammadex Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Sugammadex Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Sugammadex Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Sugammadex Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Sugammadex Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Sugammadex Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Sugammadex Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Sugammadex Industry Trends
  2. 2.2 Sugammadex Industry Drivers
  3. 2.3 Sugammadex Industry Opportunities and Challenges
  4. 2.4 Sugammadex Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Sugammadex Revenue (2021-2026)
  2. 3.2 Global Top Players by Sugammadex Sales (2021-2026)
  3. 3.3 Global Top Players by Sugammadex Price (2021-2026)
  4. 3.4 Global Sugammadex Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Sugammadex Major Company Production Sites & Headquarters
  6. 3.6 Global Sugammadex Company, Product Type & Application
  7. 3.7 Global Sugammadex Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Sugammadex Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Sugammadex Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Sugammadex Tier 1, Tier 2, and Tier 3
4 Sugammadex Regional Status and Outlook
  1. 4.1 Global Sugammadex Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Sugammadex Historic Market Size by Region
  3. 4.2.1 Global Sugammadex Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Sugammadex Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Sugammadex Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Sugammadex Forecasted Market Size by Region
  7. 4.3.1 Global Sugammadex Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Sugammadex Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Sugammadex Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Sugammadex by Application
  1. 5.1 Sugammadex Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Mobile Surgery Centre
  4. 5.2 Global Sugammadex Market Size by Application
  5. 5.2.1 Global Sugammadex Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Sugammadex Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Sugammadex Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Sugammadex Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Sugammadex Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Sugammadex Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Sugammadex Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Sugammadex Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Renfu Pharma
  2. 6.1.1 Renfu Pharma Company Information
  3. 6.1.2 Renfu Pharma Business Overview
  4. 6.1.3 Renfu Pharma Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Renfu Pharma Sugammadex Product Portfolio
  6. 6.1.5 Renfu Pharma Recent Developments
  7. 6.2 Yangzi River Pharma
  8. 6.2.1 Yangzi River Pharma Company Information
  9. 6.2.2 Yangzi River Pharma Business Overview
  10. 6.2.3 Yangzi River Pharma Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Yangzi River Pharma Sugammadex Product Portfolio
  12. 6.2.5 Yangzi River Pharma Recent Developments
  13. 6.3 Teva
  14. 6.3.1 Teva Company Information
  15. 6.3.2 Teva Business Overview
  16. 6.3.3 Teva Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Teva Sugammadex Product Portfolio
  18. 6.3.5 Teva Recent Developments
  19. 6.4 Sandoz
  20. 6.4.1 Sandoz Company Information
  21. 6.4.2 Sandoz Business Overview
  22. 6.4.3 Sandoz Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Sandoz Sugammadex Product Portfolio
  24. 6.4.5 Sandoz Recent Developments
  25. 6.5 Merck & Co
  26. 6.5.1 Merck & Co Company Information
  27. 6.5.2 Merck & Co Business Overview
  28. 6.5.3 Merck & Co Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Merck & Co Sugammadex Product Portfolio
  30. 6.5.5 Merck & Co Recent Developments
  31. 6.6 Kelun Pharma
  32. 6.6.1 Kelun Pharma Company Information
  33. 6.6.2 Kelun Pharma Business Overview
  34. 6.6.3 Kelun Pharma Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Kelun Pharma Sugammadex Product Portfolio
  36. 6.6.5 Kelun Pharma Recent Developments
  37. 6.7 Viatris
  38. 6.7.1 Viatris Company Information
  39. 6.7.2 Viatris Business Overview
  40. 6.7.3 Viatris Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Viatris Sugammadex Product Portfolio
  42. 6.7.5 Viatris Recent Developments
  43. 6.8 STADA Arzneimittel
  44. 6.8.1 STADA Arzneimittel Company Information
  45. 6.8.2 STADA Arzneimittel Business Overview
  46. 6.8.3 STADA Arzneimittel Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 STADA Arzneimittel Sugammadex Product Portfolio
  48. 6.8.5 STADA Arzneimittel Recent Developments
  49. 6.9 Intas Pharmaceuticals
  50. 6.9.1 Intas Pharmaceuticals Company Information
  51. 6.9.2 Intas Pharmaceuticals Business Overview
  52. 6.9.3 Intas Pharmaceuticals Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Intas Pharmaceuticals Sugammadex Product Portfolio
  54. 6.9.5 Intas Pharmaceuticals Recent Developments
  55. 6.10 Hikma Pharmaceuticals
  56. 6.10.1 Hikma Pharmaceuticals Company Information
  57. 6.10.2 Hikma Pharmaceuticals Business Overview
  58. 6.10.3 Hikma Pharmaceuticals Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Hikma Pharmaceuticals Sugammadex Product Portfolio
  60. 6.10.5 Hikma Pharmaceuticals Recent Developments
  61. 6.11 Fresenius
  62. 6.11.1 Fresenius Company Information
  63. 6.11.2 Fresenius Business Overview
  64. 6.11.3 Fresenius Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 Fresenius Sugammadex Product Portfolio
  66. 6.11.5 Fresenius Recent Developments
  67. 6.12 Dr Reddy's Laboratories
  68. 6.12.1 Dr Reddy's Laboratories Company Information
  69. 6.12.2 Dr Reddy's Laboratories Business Overview
  70. 6.12.3 Dr Reddy's Laboratories Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Dr Reddy's Laboratories Sugammadex Product Portfolio
  72. 6.12.5 Dr Reddy's Laboratories Recent Developments
  73. 6.13 Cipla
  74. 6.13.1 Cipla Company Information
  75. 6.13.2 Cipla Business Overview
  76. 6.13.3 Cipla Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Cipla Sugammadex Product Portfolio
  78. 6.13.5 Cipla Recent Developments
  79. 6.14 Aspen Group
  80. 6.14.1 Aspen Group Company Information
  81. 6.14.2 Aspen Group Business Overview
  82. 6.14.3 Aspen Group Sugammadex Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Aspen Group Sugammadex Product Portfolio
  84. 6.14.5 Aspen Group Recent Developments
7 North America by Country
  1. 7.1 North America Sugammadex Sales by Country
  2. 7.1.1 North America Sugammadex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Sugammadex Sales by Country (2021-2026)
  4. 7.1.3 North America Sugammadex Sales Forecast by Country (2027-2032)
  5. 7.2 North America Sugammadex Market Size by Country
  6. 7.2.1 North America Sugammadex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Sugammadex Market Size by Country (2021-2026)
  8. 7.2.3 North America Sugammadex Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Sugammadex Sales by Country
  2. 8.1.1 Europe Sugammadex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Sugammadex Sales by Country (2021-2026)
  4. 8.1.3 Europe Sugammadex Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Sugammadex Market Size by Country
  6. 8.2.1 Europe Sugammadex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Sugammadex Market Size by Country (2021-2026)
  8. 8.2.3 Europe Sugammadex Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Sugammadex Sales by Country
  2. 9.1.1 Asia-Pacific Sugammadex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Sugammadex Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Sugammadex Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Sugammadex Market Size by Country
  6. 9.2.1 Asia-Pacific Sugammadex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Sugammadex Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Sugammadex Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Sugammadex Sales by Country
  2. 10.1.1 South America Sugammadex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Sugammadex Sales by Country (2021-2026)
  4. 10.1.3 South America Sugammadex Sales Forecast by Country (2027-2032)
  5. 10.2 South America Sugammadex Market Size by Country
  6. 10.2.1 South America Sugammadex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Sugammadex Market Size by Country (2021-2026)
  8. 10.2.3 South America Sugammadex Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Sugammadex Sales by Country
  2. 11.1.1 Middle East and Africa Sugammadex Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Sugammadex Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Sugammadex Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Sugammadex Market Size by Country
  6. 11.2.1 Middle East and Africa Sugammadex Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Sugammadex Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Sugammadex Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Sugammadex Value Chain Analysis
  2. 12.1.1 Sugammadex Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Sugammadex Production Mode & Process
  7. 12.2 Sugammadex Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Sugammadex Distributors
  10. 12.2.3 Sugammadex Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst